SCHEMBL6931467

SCHEMBL6931467

COc1ccc2nn(-c3cc(CBr)ccc3O)nc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
LMNA P02545 3/20 0.43
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
MAPT P10636 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
IGF1R P08069 1/20 0.37
ALOX15 P16050 1/20 0.37
ERN1 O75460 1/20 0.36
TRIM24 O15164 1/20 0.36
TYR P14679 1/20 0.36
TRIM33 Q9UPN9 1/20 0.36
HTT P42858 1/20 0.36
CASP3 P42574 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6929101 0.88 NPC1 (0.44) NPC1RAB9ALMNAMEN1KMT2A
SCHEMBL6924417 0.83 NPC1 (0.37) NPC1RAB9ALMNAMEN1KMT2A
SCHEMBL6941182 0.81 RAB9A (0.66) NPC1RAB9ALMNAMEN1KMT2A
SCHEMBL2796744 0.81 NPC1 (0.59) NPC1RAB9ALMNAMEN1KMT2A
SCHEMBL11592476 0.80 NPC1 (0.46) NPC1RAB9ALMNAMEN1KMT2A
SCHEMBL6927141 0.80 MEN1 (0.54) NPC1RAB9ALMNAMEN1KMT2A
SCHEMBL6933818 0.80 NPC1 (0.43) NPC1RAB9ALMNAMEN1KMT2A
SCHEMBL6924415 0.79 NPC1 (0.34) NPC1RAB9ALMNAMEN1KMT2A
SCHEMBL6741920 0.79 YWHAG (0.43) NPC1RAB9ALMNAMEN1KMT2A
SCHEMBL31361782 0.79 YWHAG (0.43) NPC1RAB9ALMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6756499-B2 REACTING A BROMO-FUNCTIONALIZED BENZOTRIAZOLE ULTRAVIOLET RADIATION(UV) ABSORBER COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2004-06-29 US disclosed
US-20020082428-A1 Process for the preparation of novel diol-functionalized UV absorbers COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH 2002-06-27 US disclosed
US-6320056-B1 REACTING A 2-(2-HYDROXY-5-MEHTYLPHENYL)BENZOTIAZOLE WITH BROMINE IN PRESENCE OF NON-POLAR SOLVENT AND FREE RADICAL INITIATOR, SEPARATING SOLVENT AND PURIFYING BY RECRYSTALLIZATION; ONE STEP COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2001-11-20 US disclosed
US-6307055-B1 OPTIONALLY SUBSTITUTED 2-(2-HYDROXY-5-(N,N-BIS(HYDROXYALKYL)AMINOMETHYL)PHENYL)BENZOT RIAZOLES; UV ABSORBERS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2001-10-23 US disclosed
US-6284895-B1 Bromo-functionalized benzotriazole UV absorbers COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2001-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020082428-A1 Process for the preparation of novel diol-functionalized UV absorbers UGT1A1, ERCC1, CYP1B1 NPC1 432/4885RAB9A 1317/4885LMNA 1015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.